Sorafenib Tablets IP 200mg SORAKASO

Sorafenib Tablets IP 200mg SORAKASO


WhatsApp

Sorafenib Tablets IP 200mg SORAKASO

Composition : Sorafenib

Manufacturer : Beta Drugs ltd

Indication :  Liver cancer

Packaging : Bottle

Dosage Form : Tablet

OVERVIEW & USAGE

Brand Name - Sorafina

Generic Name – Sorakaso

Dosage Form – taken twice daily,without food at least 1 hour before or 2 hour after eating

Strength - 200mg 

Composition - Sorafenib 

Packaging - 120 tablet (1 / bottle) 

Indication - Liver cancer

Storage – store protected from light at a temperature not exceeding 30 c 

 

Side Effects Of sorakaso (Sorafenib 200mg Tablet)

Sorakaso (Sorafenib) tablets may cause some side effects. Make sure to consult your healthcare professional for the same. 

Common Side Effects 

Bleeding gums.

blistering, peeling, redness, or swelling of the palms of the hands or bottoms of the feet.

bloating of the abdomen or stomach.

blood in the urine or stools.

blurred vision.

clay-colored stools.

coughing up blood.

dark urine.

Dosage

Take Sorafina (Sorafenib 200mg Tablet) tablets as prescribed by your healthcare provider. Do not try to chew, break or crush the tablet. Take it on an empty stomach. 

Overdose 

  • In case you feel the symptoms of overdose, reach out to a doctor for help. 

Usage Of Sorakaso (Sorafenib 200mg Tablet)

Sorafenib is used to treat late-stage kidney cancer (advanced renal cell carcinoma), liver cancer (hepatocellular carcinoma) that cannot be treated by surgery, and differentiated thyroid cancer that has come back or spread to other parts of your body. Sorafenib is an antineoplastic (cancer) agent.

Warnings 

Not to be sold by retail without the prescription of a Registered Medical Practitioner 

  •  Contraception 
    • Use effective methods of contraception to prevent pregnancy while taking Sorafina tablet. 
  • Children and adolescents 
    • Sorafina tablet is not advisable for use in children and adolescents. 


Warnings For Female 

Pregnancy 

  • Sorakaso (Sorafenib) shouldn’t be used by pregnant women. Sorafenib may cause harm to the baby. It is recommended that this medicine should be avoided during pregnancy.  


Cautions

Do not break or chew the tablet. 

Not safe for pregnant women. 

Do not breastfeed while receiving this medication. 

Answer
It is a possible treatment for: a type of liver cancer called hepatocellular carcinoma